These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11473199)

  • 1. 3,4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: multidetector CT and pathology findings.
    Lawler LP; Abraham S; Fishman EK
    J Comput Assist Tomogr; 2001; 25(4):649-52. PubMed ID: 11473199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ecstasy induced acute hepatic failure. Case reports.
    Atayan Y; Çağın YF; Erdoğan MA; Harputluoglu MM; Bilgic Y
    Acta Gastroenterol Belg; 2015; 78(1):53-5. PubMed ID: 26118578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 6-2001. A 17-year-old girl with marked jaundice and weight loss.
    N Engl J Med; 2001 Feb; 344(8):591-9. PubMed ID: 11207356
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute hepatitis induced by Ecstasy].
    Indart Pérez A; Mendia Gorostidi A; Barrio Andrés J; Arens Miravé I
    Gastroenterol Hepatol; 1998 Dec; 21(10):499. PubMed ID: 9927798
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatitis from ecstasy].
    Giner Durán R; Flors H; Millán M; Manzanera R
    Gastroenterol Hepatol; 1998 Mar; 21(3):158. PubMed ID: 9607299
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute liver damage after using ecstasy].
    Shiloach E; Zecler E; Horowiz M; Scapa E
    Harefuah; 1998 Feb; 134(4):266-9, 335. PubMed ID: 10909502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe chronic hepatitis secondary to prolonged use of ecstasy and cocaine.
    Payancé A; Scotto B; Perarnau JM; de Muret A; Bacq Y
    Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):e109-13. PubMed ID: 23910059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Ecstasy"-induced hepatitis in an active duty soldier.
    Hwang I; Daniels AM; Holtzmuller KC
    Mil Med; 2002 Feb; 167(2):155-6. PubMed ID: 11873540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ("ecstasy") usage.
    Khakoo SI; Coles CJ; Armstrong JS; Barry RE
    J Clin Gastroenterol; 1995 Apr; 20(3):244-7. PubMed ID: 7797836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy").
    Cohen RS
    Biol Psychiatry; 1996 May; 39(9):819-20. PubMed ID: 8731525
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cerebral hemorrhage and "ecstasy"].
    Schlaeppi M; Prica A; de Torrenté A
    Praxis (Bern 1994); 1999 Mar; 88(13):568-72. PubMed ID: 10235031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ecstasy toxicity].
    Reingardiene D
    Medicina (Kaunas); 2006; 42(6):519-23. PubMed ID: 16816548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Variability of the clinical expression of Ecstasy-induced hepatotoxicity].
    Núñez O; Bañares R; Barrio J; Menchén L; Diego Ad; Salinero E; Clemente G
    Gastroenterol Hepatol; 2002 Oct; 25(8):497-500. PubMed ID: 12361531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ecstasy (MDMA) dependence.
    Jansen KL
    Drug Alcohol Depend; 1999 Jan; 53(2):121-4. PubMed ID: 10080038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute hepatitis due to ecstasy].
    Roques V; Perney P; Beaufort P; Hanslik B; Ramos J; Durand L; Le Bricquir Y; Blanc F
    Presse Med; 1998 Mar; 27(10):468-70. PubMed ID: 9767974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDMA-Associated Liver Toxicity: Pathophysiology, Management, and Current State of Knowledge.
    Cajanding RJM
    AACN Adv Crit Care; 2019; 30(3):232-248. PubMed ID: 31462520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute liver failure following the use of ecstasy (MDMA)].
    Lange-Brock N; Berg T; Müller AR; Fliege H; Neuhaus P; Wiedenmann B; Klapp BF; Mönnikes H
    Z Gastroenterol; 2002 Aug; 40(8):581-6. PubMed ID: 12297982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Abuse of Ecstasy (3,4-methylenedioxymethamphetamine). Pharmacological, neuropsychiatric and behavioral aspects].
    Nielsen JC; Nicholson K; Pitzner-Jørgensen BL; Undén M
    Ugeskr Laeger; 1995 Feb; 157(6):724-7. PubMed ID: 7701630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').
    McCann UD; Slate SO; Ricaurte GA
    Drug Saf; 1996 Aug; 15(2):107-15. PubMed ID: 8884162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatic and hematological complications following ecstasy usage].
    Shibolet O; Kalish Y; Gillis S; Ilan Y
    Harefuah; 2001 Oct; 140(10):911-4, 991. PubMed ID: 11681122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.